Biontech SE

Return on Assets, %

4.1

-40.3

Net income margin, %

30.9

-180

EBITDA margin, %

43.6

-168.2

Debt to Equity, %

1

3.2

Intangible assets and goodwill, %

5

0.2

Revenue CAGR 3Y, %

99.3

12.5

Total Equity change 1Y, %

4

-9

Revenue Y, % chg

-77.5

0

P/E

21.1

31

P/BV

0.9

1.8

P/S

5

10.3

EV/S

0.7

7.5

EV/EBITDA

2.8

-1.6

Average Analyst recommendation

Hold

Hold

Average upside forecasts, %

27.2

131.1

Expected dividend per share

0

0

Payout Ratio, %

0

0

Dividend Ex Date

2022-06-02